Switching from natalizumab to an anti-CD20 monoclonal antibody in relapsing remitting multiple sclerosis: A systematic review
J. Brown, Benjamin Muston, Jennifer Massey
Topics & Concepts
NatalizumabRelapsing remittingMedicineMultiple sclerosisMonoclonal antibodyMonoclonalImmunologyCD20AntibodyPolyomavirus and related diseasesMultiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders